The story of PEARS features in a new publication written to celebrate the 10th anniversary of the Patient Innovation platform. Called Patient Innovation: Inspiring stories
Exstent, a UK-based medical device company developing personalised external aortic support to preserve the natural aorta, today announced the appointment of Matt Thompson as Chief
On 1 November 2025 Tal Golesworthy was one of more than 6,000 people who took part in the 25-km 11 Beach Walk organised by the
Dr Ana Redondo was awarded the EACTS Presidents Choice Award for the top abstract in the Congenital field at EACTS 2025. Her abstract was “10
Exstent exhibited at EACTS 2025 in Copenhagen, Denmark, which took place between 8 and 11 October 2025. The Exstent team was represented by Founder and
A PEARS implant video is featured on the CTSNet homepage. The video is titled “How to Perform PEARS: A Comprehensive Guide to Personalized Aortic Root
Tal Golesworthy is leading a break out session on PEARS at the Marfan Trust’s Living with Marfan and Loeys-Dietz Syndromes Information Day, which is being held
Exstent Ltd, developer and manufacturer of the ExoVasc® Personalised External Aortic Root Support (PEARS), is pleased to announce that more than 1,400 patients have now
Tal Golesworthy recently met patient 1,338, former professional tennis player Richard Krajicek. Daphne Decker, Richard’s wife, shared a post on Instagram to share the occasion.
We develop medical devices that manage aortic dilation and minimise the risk of aortic dissection.